Fingerprint
Dive into the research topics where Matthias Kramer is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Cell-autonomous innate immunity by proteasome-derived defence peptides
Goldberg, K., Lobov, A., Antonello, P., Shmueli, M. D., Yakir, I., Weizman, T., Ulman, A., Sheban, D., Laser, E., Kramer, M. P., Shteinvil, R., Chen, G., Ibraheem, A., Sysoeva, V., Fishbain-Yoskovitz, V., Mohapatra, G., Abramov, A., Shimshi, S., Ogneva, K. & Nandy, M. & 10 others, , 27 Mar 2025, In: Nature. 639, 8056, p. 1032-1041 10 p.Research output: Contribution to journal › Article › peer-review
Open Access47 Link opens in a new tab Citations (Scopus) -
Repurposing of glatiramer acetate to treat cardiac ischemia in rodent models
Aviel, G., Elkahal, J., Umansky, K. B., Bueno-Levy, H., Petrover, Z., Kotlovski, Y., Lendengolts, D., Kain, D., Shalit, T., Zhang, L., Miyara, S., Kramer, M. P., Merbl, Y., Kozlovski, S., Alon, R., Aharoni, R., Arnon, R., Mishali, D., Katz, U. & Nachman, D. & 4 others, , Sept 2024, In: Nature Cardiovascular Research. 3, 9, p. 1049-1066 18 p.Research output: Contribution to journal › Article › peer-review
3 Link opens in a new tab Citations (Scopus) -
Corrigendum: CD84 is a regulator of the immunosuppressive microenvironment in multiple myeloma (vol 6, e141683, 2021)
Lewinsky, H., Gunes, E. G., David, K., Radomir, L., Kramer, M. P., Pellegrino, B., Perpinial, M., Chen, J., He, T. F., Mansour, A. G., Teng, K. Y., Bhattacharya, S., Caserta, E., Troadec, E., Lee, P., Feng, M., Keats, J., Krishnan, A., Rosenzweig, M. & Yu, J. & 7 others, , 24 Jul 2023, In: Africa Insight. 8, 14, 2 p.Research output: Contribution to journal › Article › peer-review
Open Access4 Link opens in a new tab Citations (Scopus) -
Post-translational modifications reshape the antigenic landscape of the MHC I immunopeptidome in tumors
Kacen, A., Javitt, A., Kramer, M. P., Morgenstern, D., Tsaban, T., Shmueli, M. D., Teo, G. C., da Veiga Leprevost, F., Barnea, E., Yu, F., Admon, A., Eisenbach, L., Samuels, Y., Schueler-Furman, O., Levin, Y., Nesvizhskii, A. I. & Merbl, Y., Feb 2023, In: Nature Biotechnology. 41, 2, p. 239-251 13 p.Research output: Contribution to journal › Article › peer-review
Open Access90 Link opens in a new tab Citations (Scopus)749 Downloads (Pure) -
The proteasome regulator PSME4 modulates proteasome activity and antigen diversity to abrogate antitumor immunity in NSCLC
Javitt, A., Shmueli, M. D., Kramer, M. P., Kolodziejczyk, A. A., Cohen, I. J., Radomir, L., Sheban, D., Kamer, I., Litchfield, K., Bab-Dinitz, E., Zadok, O., Neiens, V., Ulman, A., Wolf-Levy, H., Eisenberg-Lerner, A., Kacen, A., Alon, M., Rêgo, A. T., Stacher-Priehse, E. & Lindner, M. & 10 others, , May 2023, In: Nature Reviews Cancer. 4, 5, p. 629-647 19 p.Research output: Contribution to journal › Article › peer-review
Open Access23 Link opens in a new tab Citations (Scopus)662 Downloads (Pure)